Epileptology · Focal Cortical Dysplasia

Decoding the Pathology Report: Subtypes of FCD

At a Glance

An FCD pathology report identifies whether the dysplasia is isolated and names its subtype. Type IIb may have favorable outcomes after complete lesion removal in some surgical series, but clear margins do not guarantee seizure freedom because the seizure network can extend beyond the sampled tissue.

If your child has undergone surgery for epilepsy, you will receive a pathology report. This document uses a classification system created by the International League Against Epilepsy (ILAE) to describe exactly how the brain’s structure was disrupted ^[1].

Understanding these subtypes is important because they can help explain why the seizures were difficult to treat. However, pathology is an important evaluation, not the absolute “final word” on the entire seizure network, as it is limited to the tissue that was sampled and removed.

The ILAE Classification: Isolated vs. Associated

The first thing to look for is whether the FCD is isolated or associated with another condition:

Isolated FCD (Types I and II): This means the dysplasia is the primary issue in that area of the brain ^[1].
Associated FCD (Type III): This is when FCD-like changes are found next to another principal lesion, such as a scar from a previous injury, a tumor, or a vascular malformation ^[2]^[3].

Type I: Subtle Architecture Changes

FCD Type I is often the most difficult to see on an MRI. In this type, the “layers” of the brain (the lamination) are disorganized, but the individual brain cells usually look relatively normal under a microscope ^[4]^[5].

Type Ia: The cells are lined up in abnormal vertical columns ^[4].
Type Ib: The horizontal layers of the brain are blurred or missing ^[4].
Type Ic: A combination of both abnormal columns and blurred layers ^[6].

In pediatric surgical studies, Type I is sometimes associated with an earlier start to seizures and may be more challenging to treat surgically because the epileptogenic network can be broader and harder to define than what is visible on scans ^[7]^[8]^[9].

Type II: “Mismade” Brain Cells

FCD Type II is characterized by the presence of clearly abnormal, “mismade” cells. These lesions are often more visible on a high-quality MRI ^[10].

Type IIa (Dysmorphic Neurons): The brain contains dysmorphic neurons—cells that are much larger than normal, have an odd shape, and are oriented the wrong way ^[11]^[12].
Type IIb (Balloon Cells): This type contains both dysmorphic neurons and balloon cells ^[11]. Balloon cells are massive, pale cells that look like inflated balloons under the microscope. They are a hallmark of a highly active mTOR pathway ^[13]^[5].

Why the Subtype Matters for Surgery

While every child is unique, research has shown patterns in how these subtypes respond to surgery. Generally, Type IIb (with balloon cells) tends to have favorable outcomes, with some highly selected surgical cohorts reporting success rates as high as 88% after five years, provided the entire lesion is removed ^[14]^[15].

Type I and Type IIa can sometimes be more “diffuse,” meaning the edges of the abnormality are harder to find, which can make complete surgical removal more complex ^[14]^[15]. Regardless of the type, one of the most important predictors of success is the complete resection (removal) of the entire abnormal area ^[16].

Pathology Report Checklist

When you review your child’s pathology report, look for these key data points to ensure you have a complete picture. Keep in mind that FCD is not a tumor with simple oncologic margins, and clear margins on sampled tissue do not absolutely guarantee total seizure freedom.

The Specific Subtype: Does it clearly state Type I (a, b, or c) or Type II (a or b)? ^[1]
Cell Types Found: Does it mention dysmorphic neurons or balloon cells? ^[11]
Special Stains (Immunohistochemistry): Did they use stains like NeuN (to see the layers), pS6 (to check for mTOR activity), or alpha-B-crystallin (to find balloon cells)? ^[5]^[12]^[17]
Somatic Genetic Testing: If the tissue was sent for genetic analysis, does the report identify any mutations in genes like MTOR, TSC1, or TSC2? ^[18]^[19]
Margin Status: Does the report note if the abnormal cells were found all the way to the edge of the removed tissue, or if the “margins” were clear? ^[18]

Common questions in this guide

What does isolated focal cortical dysplasia mean on a pathology report?

Isolated FCD means the dysplasia is the primary abnormality found in that area of brain tissue, rather than being next to another main lesion. The report may classify it as Type I or Type II; Type III is used when FCD-like changes occur beside a scar, tumor, or vascular malformation.

How do FCD Type I, Type IIa, and Type IIb differ?

Type I mainly involves disorganized layers of the cerebral cortex, while the nerve cells may look relatively typical. Type IIa includes unusually shaped nerve cells called dysmorphic neurons, and Type IIb includes dysmorphic neurons plus balloon cells.

What do balloon cells mean in a child’s FCD pathology report?

Balloon cells are very large, pale cells seen under the microscope and are a characteristic feature of FCD Type IIb. Their presence supports that subtype, but the pathologist interprets them with the rest of the tissue findings rather than using one cell type alone.

Can the FCD subtype predict whether epilepsy surgery will stop seizures?

The subtype can provide clues but cannot predict an individual child’s outcome. Type IIb has shown favorable results in some selected surgical series, while Type I and Type IIa may be more diffuse; complete removal of the abnormal area is an important predictor, but it does not guarantee seizure freedom.

What tests or stains might be listed in an FCD pathology report?

NeuN may help show how the brain layers are arranged, pS6 may indicate activity in the mTOR pathway, and alpha-B-crystallin may help identify balloon cells. Tissue testing may also look for somatic mutations in MTOR, TSC1, or TSC2.

Do clear margins mean my child will be seizure-free?

No. FCD is not a tumor with simple cancer-style margins, and a report only describes the tissue that was sampled and removed. Complete removal of the abnormal area can improve the chance of seizure control, but the seizure network may extend beyond that tissue.

Should a specialized neuropathologist review my child’s FCD report?

Ask whether the report was reviewed by a neuropathologist who specializes in epilepsy. Subtype, stains, and margins are best interpreted together with MRI findings and the rest of the epilepsy evaluation.

Get notified when new evidence is published on Isolated focal cortical dysplasia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (19)

1
The ILAE consensus classification of focal cortical dysplasia: An update proposed by an ad hoc task force of the ILAE diagnostic methods commission.
Najm I, Lal D, Alonso Vanegas M, et al.
Epilepsia 2022; (63(8)):1899-1919 doi:10.1111/epi.17301.
PMID: 35706131
2
The epileptologist's perspective of focal cortical dysplasia type 3: From concept to management.
Palmini A, Oliveira F, Paglioli E, et al.
Epilepsia 2026; (67(3)):1017-1031 doi:10.1111/epi.70023.
PMID: 41277749
3
A distinct clinicopathological variant of focal cortical dysplasia IIId characterized by loss of layer 4 in the occipital lobe in 12 children with remote hypoxic-ischemic injury.
Wang DD, Piao YS, Blumcke I, et al.
Epilepsia 2017; (58(10)):1697-1705 doi:10.1111/epi.13855.
PMID: 28833053
4
Pathological Classification of Focal Cortical Dysplasia (FCD) : Personal Comments for Well Understanding FCD Classification.
Kim SH, Choi J
Journal of Korean Neurosurgical Society 2019; (62(3)):288-295 doi:10.3340/jkns.2019.0025.
PMID: 31085954
5
Focal cortical dysplasia pathology: diagnostic difficulty, classification, and utility for pathogenesis.
Kapar O, Gurkan ZM, Dolgun M, et al.
Neurosurgical focus 2022; (53(4)):E6 doi:10.3171/2022.7.FOCUS21731.
PMID: 36183176
6
SLC35A2 somatic variants in drug resistant epilepsy: FCD and MOGHE.
Elziny S, Crino PB, Winawer M
Neurobiology of disease 2023; (187()):106299 doi:10.1016/j.nbd.2023.106299.
PMID: 37739137
7
Surgical treatment of pediatric focal cortical dysplasia: Clinical spectrum and surgical outcome.
Kwon HE, Eom S, Kang HC, et al.
Neurology 2016; (87(9)):945-51 doi:10.1212/WNL.0000000000003042.
PMID: 27466475
8
A new perspective on drug-resistant epilepsy in children with focal cortical dysplasia type 1: From challenge to favorable outcome.
Splitkova B, Mackova K, Koblizek M, et al.
Epilepsia 2025; (66(3)):632-647 doi:10.1111/epi.18237.
PMID: 39724384
9
Cognitive functioning after epilepsy surgery in children with mild malformation of cortical development and focal cortical dysplasia.
Veersema TJ, van Schooneveld MMJ, Ferrier CH, et al.
Epilepsy & behavior : E&B 2019; (94()):209-215 doi:10.1016/j.yebeh.2019.03.009.
PMID: 30974349
10
Multimodal MRI profiling of focal cortical dysplasia type II.
Hong SJ, Bernhardt BC, Caldairou B, et al.
Neurology 2017; (88(8)):734-742 doi:10.1212/WNL.0000000000003632.
PMID: 28130467
11
Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis.
Lee WS, Baldassari S, Stephenson SEM, et al.
International journal of molecular sciences 2022; (23(3)) doi:10.3390/ijms23031344.
PMID: 35163267
12
Clinical, imaging, and immunohistochemical characteristics of focal cortical dysplasia Type II extratemporal epilepsies in children: analyses of an institutional case series.
Knerlich-Lukoschus F, Connolly MB, Hendson G, et al.
Journal of neurosurgery. Pediatrics 2017; (19(2)):182-195 doi:10.3171/2016.8.PEDS1686.
PMID: 27885945
13
Transcriptome analyses of the cortex and white matter of focal cortical dysplasia type II: Insights into pathophysiology and tissue characterization.
Assis-Mendonça GR, Athié MCP, Tamanini JVG, et al.
Frontiers in neurology 2023; (14()):1023950 doi:10.3389/fneur.2023.1023950.
PMID: 37006485
14
Surgical outcome and predictive factors of epilepsy surgery in pediatric isolated focal cortical dysplasia.
Choi SA, Kim SY, Kim H, et al.
Epilepsy research 2018; (139()):54-59 doi:10.1016/j.eplepsyres.2017.11.012.
PMID: 29197666
15
Surgical strategy for focal cortical dysplasia based on the analysis of the spike onset and peak zones on magnetoencephalography.
Shirozu H, Hashizume A, Masuda H, et al.
Journal of neurosurgery 2020; (133(6)):1850-1862 doi:10.3171/2019.6.JNS191058.
PMID: 31585422
16
Seizure Outcome After Surgery for MRI-Diagnosed Focal Cortical Dysplasia: A Systematic Review and Meta-analysis.
Willard A, Antonic-Baker A, Chen Z, et al.
Neurology 2022; (98(3)):e236-e248 doi:10.1212/WNL.0000000000013066.
PMID: 34893558
17
A controversial question: Can morphometry and clinical history be enough to diagnose hippocampal dysplasia?
Arruda IL, Arruda RF, da Silveira RMB, et al.
Epileptic disorders : international epilepsy journal with videotape 2024; (26(3)):382-391 doi:10.1002/epd2.20222.
PMID: 38588048
18
mTOR Pathway Somatic Pathogenic Variants in Focal Malformations of Cortical Development: Novel Variants, Topographic Mapping, and Clinical Outcomes.
Krochmalnek E, Accogli A, St-Onge J, et al.
Neurology. Genetics 2023; (9(6)):e200103 doi:10.1212/NXG.0000000000200103.
PMID: 37900581
19
Profiling PI3K-AKT-MTOR variants in focal brain malformations reveals new insights for diagnostic care.
Pirozzi F, Berkseth M, Shear R, et al.
Brain : a journal of neurology 2022; (145(3)):925-938 doi:10.1093/brain/awab376.
PMID: 35355055

This page is for informational purposes only and does not constitute medical advice. Your child’s epilepsy team and a specialized epilepsy neuropathologist should interpret the pathology report, MRI findings, and surgical outlook together.